https://www.selleckchem.com/products/hg6-64-1.html
After 24 weeks of ART, between-group differences in CD4/CD8 cell ratio lessened (p=0.09 overall), but differences between those initiating ART ≤30 days from EDDI (median 1.03, IQR 0.84, 1.37), and those initiating 90 days (0.88, IQR 0.61, 1.11) remained, p=0.02. Principal components analysis of 20 immune biomarkers demonstrated distinct patterns between those starting ART 90 days from EDDI vs those starting within 30 or 90 days (both p less then 0.001). CONCLUSIONS To our knowledge, this is the only evaluation of randomized ART
Like
Comment
Share
